🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "specific steps to deal with household expense issues" in the upcoming financial statement.

In comments to media outlets, she stated that curbing inflation is a shared responsibility of both the administration and the Bank of England.

The UK's inflation rate is expected to be the most elevated among the Group of Seven advanced economies this year and the following year.

Possible Energy Bill Interventions

Sources suggest the government could take action to reduce energy bills, for instance by slashing the current 5% level of value-added tax charged on energy.

Another option is to cut some of the government charges currently added to household expenses.

Budgetary Limitations and Analyst Expectations

The administration will obtain the next draft from the independent fiscal watchdog, the OBR, on Monday, which will show how much scope there is for such actions.

The expectation from most experts is that Reeves will have to announce higher taxes or budget cuts in order to fulfill her self-imposed borrowing rules.

Previously on the same day, analysis suggested there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the lower end of expectations.

"There's a joint responsibility between the central bank and the administration to bear down further on some of the causes of price increases," the Chancellor stated to reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and Global Concerns

While a great deal of the attention has been on probable tax increases, the chancellor said the latest figures from the OBR had not altered her vow to manifesto promises not to increase rates on earnings tax, VAT or social security contributions.

She blamed an "uncertain world" with increasing international and commercial concerns for the fiscal tax moves, probably to be targeted on those "with the broadest shoulders."

International Economic Disputes

Referring to concerns about the United Kingdom's trade ties with China she said: "Our security interests invariably come first."

Last week's declaration by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are essential for high-technology production led US President Donald Trump to threaten an further 100% import tax on goods from China, increasing the possibility of an full-scale trade war between the two global powers.

The American finance chief called China's decision "commercial pressure" and "a global supply chain control attempt."

Questioned on accepting the US offer to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by China's measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the action was "damaging for the global economy and creates additional headwinds."

"In my view there are sectors where we should confront China, but there are also significant prospects to export to China's economy, including financial services and other sectors of the economy. We've got to maintain that equilibrium right."

The chancellor also stated she was collaborating with international partners "regarding our own essential resources approach, so that we are less reliant."

NHS Drug Pricing and Funding

The Chancellor also recognized that the cost the National Health Service spends on pharmaceuticals could go up as a result of current negotiations with the Trump administration and its drugs companies, in return for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning projects in the UK, with several attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the price the NHS pays for medicines would need to go up to stop businesses and pharmaceutical investment leaving the UK.

The Chancellor told media: "We have seen because of the payment system, that medical research, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other European countries."

"Our aim is to ensure that people receiving treatment from the National Health Service are can obtain the best life-saving treatments in the globe. And so we are looking at all of that, and... seeking to obtain more capital into Britain."